Ralph Carbone, DO
Interventional Pain Medicine · Mishawaka, INNPI 1447212006
Payments from drug & device makers
Across 494 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Scilex Pharmaceuticals Inc.$1K
- Collegium Pharmaceutical, Inc.$1K
- Medtronic$748
- Amgen$272
- Abbott$260
- plus $2K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 153 | $2,088 |
| Scilex Pharmaceuticals Inc. | 65 | $1,206 |
| Collegium Pharmaceutical, Inc. | 93 | $1,024 |
| Medtronic(2 entities) | 42 | $748 |
| Amgen | 19 | $272 |
| Abbott | 3 | $260 |
| Teva Pharmaceuticals USA, Inc. | 16 | $210 |
| Pfizer | 10 | $180 |
| Orexo US, Inc. | 9 | $175 |
| Lilly USA, LLC | 7 | $163 |
| Biodelivery Sciences International, Inc. | 10 | $151 |
| Indivior Inc. | 8 | $150 |
| Idorsia Pharmaceuticals US Inc | 2 | $145 |
| Tersera Therapeutics LLC | 5 | $131 |
| Zyla Life Sciences, Inc. | 11 | $123 |
| Corium, LLC | 1 | $113 |
| Boston Scientific | 8 | $108 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $107 |
| Almatica Pharma LLC | 4 | $63 |
| AstraZeneca | 5 | $56 |
| Assertio Therapeutics, Inc. | 4 | $44 |
| Redhill Biopharma Inc. | 2 | $43 |
| GRT US Holding, Inc. | 2 | $37 |
| Nevro Corp. | 2 | $35 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $23 |
| Alkermes, Inc. | 1 | $21 |
| AbbVie | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Vertex | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Shionogi Inc | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$7,827 in reported general payments places this provider in the 70th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Mishawaka
- Ajit PaiMishawaka$6K
- Joshua WellingtonCarmel$315K
- Mahendra SanapatiEvansville$219K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.